These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8290248)

  • 1. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.
    Takada S; Kido H; Fukutomi A; Mori T; Koike K
    Oncogene; 1994 Feb; 9(2):341-8. PubMed ID: 8290248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of hepatocarcinogenesis by hepatitis B virus].
    Takada S; Koike K
    Nihon Rinsho; 1993 Feb; 51(2):364-9. PubMed ID: 8385238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins.
    Takada S; Koike K
    Virology; 1994 Dec; 205(2):503-10. PubMed ID: 7975252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
    Kido H; Niwa Y; Beppu Y; Towatari T
    Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues.
    Brinkmann T; Schäfers J; Gürtler L; Kido H; Niwa Y; Katunuma N; Tschesche H
    J Protein Chem; 1997 Aug; 16(6):651-60. PubMed ID: 9263127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
    J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
    Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
    Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of three essential regions of hepatitis B virus X protein for trans-activation function.
    Arii M; Takada S; Koike K
    Oncogene; 1992 Mar; 7(3):397-403. PubMed ID: 1549357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
    Kido H; Fukutomi A; Katunuma N
    FEBS Lett; 1991 Jul; 286(1-2):233-6. PubMed ID: 1677898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a subgroup of glycosylphosphatidylinositol-anchored tryptases.
    Wong GW; Stevens RL
    Biochem Biophys Res Commun; 2005 Oct; 336(2):579-84. PubMed ID: 16143303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close co-localization of CD4 and a serine esterase tryptase TL2 on the cell-surface of human monocytoid and CD4+ lymphoid cells.
    Inoue M; Hoshino T; Fukuma T; Niwa Y; Kido H
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1390-5. PubMed ID: 7912927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
    Fiorucci L; Erba F; Ascoli F
    Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X protein of hepatitis B virus resembles a serine protease inhibitor.
    Takada S; Koike K
    Jpn J Cancer Res; 1990 Dec; 81(12):1191-4. PubMed ID: 2125986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of recombinant gamma-tryptase.
    Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM
    Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry and functions of hepatitis B virus X protein.
    Koike K; Takada S
    Intervirology; 1995; 38(1-2):89-99. PubMed ID: 8666528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition.
    Rohr KB; Selwood T; Marquardt U; Huber R; Schechter NM; Bode W; Than ME
    J Mol Biol; 2006 Mar; 357(1):195-209. PubMed ID: 16414069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.